Literature DB >> 18554662

Percent tumor involvement and risk of biochemical progression after radical prostatectomy.

Edward N Rampersaud1, Leon Sun, Judd W Moul, John Madden, Stephen J Freedland.   

Abstract

PURPOSE: Percent tumor involvement has been associated with biochemical progression in organ confined disease, although its role in predicting outcome in men with more advanced disease pathology is unclear. We hypothesized percent tumor involvement may be a good correlate of outcome in all stages of prostate cancer.
MATERIALS AND METHODS: We examined the association between percent tumor involvement in the radical prostatectomy specimen and the outcome measures of pathological stage and biochemical progression using multivariate logistic regression and Cox proportional hazards analysis, respectively, in 2,220 patients from the Duke Prostate Center radical prostatectomy database.
RESULTS: On multivariate analysis, percent tumor involvement significantly predicted the risk of positive margins (p <0.001), extracapsular extension (p <0.001), seminal vesicle invasion (p <0.001) and biochemical progression (HR 1.16, 95% CI 1.01-1.33, p = 0.035). The percent tumor involvement cut points of 5% or less, 6% to 20%, 21% to 50% and greater than 50% significantly separated men in groups with differing biochemical progression risk (p <0.001). In addition, these cut points were further able to stratify men among those with organ confined margin negative disease (p <0.001), either positive margins or extracapsular extension (p <0.001), and those with seminal vesicle invasion (p = 0.02).
CONCLUSIONS: Percent tumor involvement was a significant predictor of biochemical progression and was able to further stratify men who were already assigned to narrowly defined pathological groups. If confirmed in other studies, percent tumor involvement may enable the clinician to identify the high risk patient who stands to benefit the most from adjuvant therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18554662     DOI: 10.1016/j.juro.2008.04.017

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  14 in total

1.  Tumor volume as a predictor of adverse pathologic features and biochemical recurrence (BCR) in radical prostatectomy specimens: a tale of two methods.

Authors:  Ian M Thompson; Shady Salem; Sam S Chang; Peter E Clark; Rodney Davis; S Duke Herrell; Yakup Kordan; Roxelyn Baumgartner; Sharon Phillips; Joseph A Smith; Michael S Cookson; Daniel A Barocas
Journal:  World J Urol       Date:  2010-11-16       Impact factor: 4.226

2.  Do tumor volume, percent tumor volume predict biochemical recurrence after radical prostatectomy? A meta-analysis.

Authors:  Yang Meng; He Li; Peng Xu; Jia Wang
Journal:  Int J Clin Exp Med       Date:  2015-12-15

3.  Percent tumor volume predicts biochemical recurrence after radical prostatectomy: multi-institutional data analysis.

Authors:  Cheryn Song; Seongil Seo; Hanjong Ahn; Seok-Soo Byun; Jin Seon Cho; Young Deuk Choi; Eunsik Lee; Hyun Moo Lee; Sang Eun Lee; Han Yong Choi
Journal:  Int J Clin Oncol       Date:  2011-08-05       Impact factor: 3.402

4.  Does salvage radiation therapy change the biology of recurrent prostate cancer based on PSA doubling times? Results from the SEARCH database.

Authors:  Roberto L Muller; Joseph C Presti; William J Aronson; Martha K Terris; Christopher J Kane; Christopher L Amling; Stephen J Freedland
Journal:  Urology       Date:  2012-03-23       Impact factor: 2.649

5.  The prognostic significance of percentage of tumour involvement according to disease risk group in men treated with radical prostatectomy.

Authors:  Jong Jin Oh; Sang Cheol Lee; Chang Wook Jeong; Cheol Yong Yoon; Seong Jin Jeong; Sung Kyu Hong; Seok-Soo Byun; Yoon Kwan Rho; Gheeyoung Choe; Sang Eun Lee
Journal:  Asian J Androl       Date:  2011-09-26       Impact factor: 3.285

6.  The association between tumour density and prostate cancer recurrence following radical prostatectomy.

Authors:  Luke T Lavallée; Rodney H Breau; Mark A Preston; Gayanna Raju; Christopher Morash; Steve Doucette; Ronald G Gerridzen; James Eastham; Ilias Cagiannos
Journal:  Can Urol Assoc J       Date:  2011-12       Impact factor: 1.862

7.  Matrix-metalloproteinases in head and neck carcinoma-cancer genome atlas analysis and fluorescence imaging in mice.

Authors:  Samantha J Hauff; Sharat C Raju; Ryan K Orosco; Andrew M Gross; Julio A Diaz-Perez; Elamprakash Savariar; Nadia Nashi; Jonathan Hasselman; Michael Whitney; Jeffrey N Myers; Scott M Lippman; Roger Y Tsien; Trey Ideker; Quyen T Nguyen
Journal:  Otolaryngol Head Neck Surg       Date:  2014-08-04       Impact factor: 3.497

8.  Tumor volume, tumor percentage involvement, or prostate volume: which is predictive of prostate-specific antigen recurrence?

Authors:  Matthew A Uhlman; Leon Sun; Danielle A Stackhouse; Arthur A Caire; Thomas J Polascik; Cary N Robertson; John Madden; Robin Vollmer; David M Albala; Judd W Moul
Journal:  Urology       Date:  2009-10-12       Impact factor: 2.649

9.  Tumor volume improves the long-term prediction of biochemical recurrence-free survival after radical prostatectomy for localized prostate cancer with positive surgical margins.

Authors:  Christian P Meyer; Jens Hansen; Katharina Boehm; Derya Tilki; Firas Abdollah; Quoc-Dien Trinh; Margit Fisch; Guido Sauter; Markus Graefen; Hartwig Huland; Felix K H Chun; Sascha A Ahyai
Journal:  World J Urol       Date:  2016-06-03       Impact factor: 4.226

10.  Clinical Usefulness of Prostate and Tumor Volume Related Parameters following Radical Prostatectomy for Localized Prostate Cancer.

Authors:  Yujiro Ito; Kazuma Udo; Emily A Vertosick; Daniel D Sjoberg; Andrew J Vickers; Hikmat A Al-Ahmadie; Ying-Bei Chen; Anuradha Gopalan; S Joseph Sirintrapun; Satish K Tickoo; Peter T Scardino; James A Eastham; Victor E Reuter; Samson W Fine
Journal:  J Urol       Date:  2019-03       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.